Skip to content

MIRA PHARMACEUTICALS, INC.

MIRA

CIK 0001904286 · Pharmaceutical Preparations · Nasdaq

  • Mira1a Therapeutics, Inc. (until 2023-05-02)
← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$5.61M
−33.0% YoY Q1 May 2026
EPS Diluted (TTM)
−$1.41
−164.7% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
—
Q1 May 2026
Cash
$4.82M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
42.02M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings